Viking Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Viking Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About VKTX
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A.
CEOBrian Lian
CEOBrian Lian
Employees36
Employees36
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2012
Founded2012
Employees36
Employees36
VKTX Key Statistics
Market cap4.16B
Market cap4.16B
Price-Earnings ratio-17.38
Price-Earnings ratio-17.38
Dividend yield—
Dividend yield—
Average volume3.30M
Average volume3.30M
High today$36.89
High today$36.89
Low today$36.08
Low today$36.08
Open price$36.45
Open price$36.45
Volume1.19M
Volume1.19M
52 Week high$54.54
52 Week high$54.54
52 Week low$18.92
52 Week low$18.92
Stock Snapshot
The current Viking Therapeutics(VKTX) stock price is $36.33, with a market capitalization of 4.16B. The stock trades at a price-to-earnings (P/E) ratio of -17.38.
On 2025-11-29, Viking Therapeutics(VKTX) stock traded between a low of $36.08 and a high of $36.89. Shares are currently priced at $36.33, which is +0.7% above the low and -1.5% below the high.
Viking Therapeutics(VKTX) shares are trading with a volume of 1.19M, against a daily average of 3.3M.
During the past year, Viking Therapeutics(VKTX) stock moved between $18.92 at its lowest and $54.54 at its peak.
During the past year, Viking Therapeutics(VKTX) stock moved between $18.92 at its lowest and $54.54 at its peak.
Analyst ratings
94%
of 18 ratingsBuy
94.4%
Hold
5.6%
Sell
0%
People also own
Based on the portfolios of people who own VKTX. This list is generated using Robinhood data, and it’s not a recommendation.